Anita Fauchier

Anita Fauchier is an accomplished regulatory affairs professional with extensive experience in the biopharmaceutical and medical device industries. Currently serving as Vice President of Global Regulatory Affairs Aesthetics at AbbVie since September 2022, Anita previously held leadership positions including Vice President of Regulatory Affairs at Palladio Biosciences, where the focus was on developing a treatment for a rare kidney disease, and Vice President of Regulatory Affairs and Quality at Airway Therapeutics and Therabron Therapeutics, where efforts were directed towards respiratory diseases in vulnerable populations. Anita has a proven track record of securing regulatory designations, implementing quality systems, and managing teams, contributing to the advancement of innovative therapies. Prior roles include Executive Director of Regulatory Affairs CMC at Cempra Pharmaceuticals and a Specialist in Regulatory and Quality Affairs at the U.S. Department of Health and Human Services' BARDA. Education includes completion of studies at Lee University.